TP53 and PTEN as driver mutations in Zenker's carcinoma—a clinical presentation

by Zsanett Noel, Sylvia Hoeller, Michel Bihl, Laurent Muller
Published 2020-12-01

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

by Florence Baettig, Tatjana Vlajnic, Marcus Vetter, Katharina Glatz, Jürgen Hench, Stephan Frank, Michel Bihl, Roberto Lopez, Michael Dobbie, Viola Heinzelmann-Schwarz, Céline Montavon
Published 2019-10-01

SalvGlandDx – a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets

by Sandra N. Freiberger, Muriel Brada, Christine Fritz, Sylvia Höller, Alexander Vogetseder, Milo Horcic, Michel Bihl, Michal Michal, Martin Lanzer, Martin Wartenberg, Urs Borner, Peter K. Bode, Martina A. Broglie, Tamara Rordorf, Grégoire B. Morand, Niels J. Rupp
Published 2021-05-01

Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study

by Cecily P. Vaughn, José Luis Costa, Harriet E. Feilotter, Rosella Petraroli, Varun Bagai, Anna Maria Rachiglio, Federica Zito Marino, Bastiaan Tops, Henriette M. Kurth, Kazuko Sakai, Andrea Mafficini, Roy R. L. Bastien, Anne Reiman, Delphine Le Corre, Alexander Boag, Susan Crocker, Michel Bihl, Astrid Hirschmann, Aldo Scarpa, José Carlos Machado, Hélène Blons, Orla Sheils, Kelli Bramlett, Marjolijn J. L. Ligtenberg, Ian A. Cree, Nicola Normanno, Kazuto Nishio, Pierre Laurent-Puig
Published 2018-08-01